Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Barnes

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Thorax|October 1, 1996
Pleural fluid accumulation due to intra-abdominal endometriosis: a case report and review of the literatureK L Flanagan, N C Barnes
The European Respiratory Journal|September 4, 2007
Eppur si muove, or COPD treatment success and inflammationJ B Soriano, N C Barnes
Thorax|May 19, 2000
Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trialsN C Barnes, C J Miller
British Medical Bulletin|April 1, 1987
Airway hyperresponsiveness and inflammationN C Barnes, J F Costello
Thorax|June 1, 1997
Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthmaN C Barnes, J C Pujet
Thorax|November 1, 1996
Risk of severe life threatening asthmaN C Barnes, L M Kuitert
Lancet (London, England)|March 21, 1998
Non-steroidal anti-inflammatory therapy for asthmaA B Kay, N C Barnes
British Journal of Diseases of the Chest|January 1, 1988
Evaluation of a hand-held spirometer, the Respiradyne, for the measurement of forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PEFR)S C Jenkins, N C Barnes, J Moxham
BMJ (Clinical Research Ed.)|February 6, 1993
Monitoring treatment with aminoglycoside antibioticsC D Sheldon, H Gaya, N C Barnes
Respiratory Medicine|March 31, 1998
Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or lessN C Barnes, C Hallett, T A Harris
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Thorax|October 1, 1996
Pleural fluid accumulation due to intra-abdominal endometriosis: a case report and review of the literatureK L Flanagan, N C Barnes
The European Respiratory Journal|September 4, 2007
Eppur si muove, or COPD treatment success and inflammationJ B Soriano, N C Barnes
Thorax|May 19, 2000
Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trialsN C Barnes, C J Miller
British Medical Bulletin|April 1, 1987
Airway hyperresponsiveness and inflammationN C Barnes, J F Costello
Thorax|June 1, 1997
Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthmaN C Barnes, J C Pujet
Thorax|November 1, 1996
Risk of severe life threatening asthmaN C Barnes, L M Kuitert
Lancet (London, England)|March 21, 1998
Non-steroidal anti-inflammatory therapy for asthmaA B Kay, N C Barnes
British Journal of Diseases of the Chest|January 1, 1988
Evaluation of a hand-held spirometer, the Respiradyne, for the measurement of forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PEFR)S C Jenkins, N C Barnes, J Moxham
BMJ (Clinical Research Ed.)|February 6, 1993
Monitoring treatment with aminoglycoside antibioticsC D Sheldon, H Gaya, N C Barnes
Respiratory Medicine|March 31, 1998
Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or lessN C Barnes, C Hallett, T A Harris
Pageof 10